Sir Steve Jackson elected as AACR Fellow in the Class of 2026

In their press release, the AACR noted that Professor Jackson was selected for his revered contributions to defining cellular DNA damage responses (DDR), including the discovery of DNA-dependent protein kinase (DNA-PK) and the core machinery of non-homologous end joining as well as for elucidating how ATM and ATR kinases, and key post-translational modifications preserve genome stability, work which has led to the development of DDR inhibitors and establishment of synthetic lethality as a transformative cancer treatment paradigm.

The mission of the Fellows of the AACR Academy is to recognize and honor extraordinary scientists whose groundbreaking contributions have driven significant innovation and progress in the fight against cancer. Fellows of the AACR Academy constitute a global brain trust of leading experts in cancer science and medicine, working to advance the AACR’s mission to prevent and cure all cancers through research, education, collaboration, communication, advocacy, and funding for cancer research.

Fellows of the AACR Academy are nominated and elected through a meticulous, multistep, peer-reviewed process that rigorously evaluates each candidate’s scientific achievements and contributions to the global cancer research community. Only those whose work has made a profound and lasting impact on cancer research and related fields are considered for election and induction into the AACR Academy.